Knapen, L. M., Koornstra, R. H. T., Driessen, J. H. M., van Vlijmen, B., Croes, S., Schalkwijk, S., . . . van Erp, N. P. (2018). The Impact of Dose and Simultaneous Use of Acid-Reducing Agents on the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: A Retrospective Cohort Study. Target Oncol.
Chicago ZitierstilKnapen, Lotte M., et al. "The Impact of Dose and Simultaneous Use of Acid-Reducing Agents On the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: A Retrospective Cohort Study." Target Oncol 2018.
MLA ZitierstilKnapen, Lotte M., et al. "The Impact of Dose and Simultaneous Use of Acid-Reducing Agents On the Effectiveness of Vemurafenib in Metastatic BRAF V600 Mutated Melanoma: A Retrospective Cohort Study." Target Oncol 2018.